Optimizing type 2 diabetes care with GLP-1 RA and dual GIP/GLP-1 RA therapy
In this course, real-life events are discussed to help pharmacists improve health outcomes for individuals with type 2 diabetes in their practices by applying guideline-directed care to optimize GLP-1 RA or dual GIP/GLP-1 RA therapy.
This course is accredited by CCCEP for 1.25 CEUs; course number CCCEP #1329-2024-3804-I-P.
Supported by an unrestricted educational grant from Novo Nordisk Canada
Note: This course was previously titled "Where’s the Diabetes- Related-Problem? Or are we the Problem?”
Learning Objectives
Upon successful completion of this continuing education lesson, you will be better able to:
- Identify people with type 2 diabetes in your practice who need your help.
- Initiate conversations with people with type 2 diabetes to proactively improve their health
outcomes. - Apply guideline-directed care to show individuals with type 2
diabetes how you can practically (re-)start, optimize, and monitor GLP-1 RA or dual GIP/GLP-1 RA therapy.
Course Author: Susie Jin
This continuing education is free for members of CanadianHealthcareNetwork.ca. Log in and click here to take the course:
Not a member of CanadianHealthcareNetwork?
Registration is free and easy for qualified healthcare professionals.